A postulated reason for this discrepancy may be the different inclusion criteria of cardiomyopathy, with several studies that reported the lack of association between TNF-a polymorphisms and DCM mainly included patients with New York Heart Association (NYHA) class II or III, with only a small number of patients with end-stage heart failure. Here, TNF is linked to familial dilated cardiomyopathy.